You missed my point.
Dilution can be managed and mitigated by company growth,
revenue growth, dispensary license, clean balance sheet,
catalysts that continue driving up volume and the pps,
while allowing debt conversion, without having a " toxic "
effect.
I happen to think the sector will continue allowing these
catalysts coming to fruition.
You obviously don't.
Maybe a stock trading over the Nasdaq, at a much higher
pps, would better suit your trading needs.
News 
Market Data 
Discover 
AI
